Biognos AB

Virtual Screening - Drug Discovery

Biognos provides services in computational drug design especially virtual screening (in silico-screening) and lead optimization. Using our software and our computer cluster we can quickly identify potential lead compounds in large libraries of small molecules. Our ligand-based screening allows scoffold hopping and in many cases circumvention of patents. We offer our expertise mainly to pharmaceutical companies. We have a special competence in the design of glycomimetic compounds. Biognos also provides services for academic groups.
Business Unit Director
Per-Georg Nyholm
Our services in ligand-based and structure-based drug design is a cost-efficient alternative for smaller pharmaceutical companies
  • Category
    Biotech
  • Founded
    2003
  • Public company
    No
  • Number of employees
    3
  • Chairman
    Nina Granath
  • Principal owners
    Nina Granath & Per-Georg Nyholm
Patents, projects and products